Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Potential for linearity defect with the tina-quant albumine urine has been identified by the manufacturer leading to a temporary reduction of the upper measuring range. this assay can be used on the cobas c111 system.